CA
IHE icon

Continuum Advisory’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Continuum Advisory’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-87
Closed -$6.14K – 958
2025
Q1 		$6.14K Hold
87
– – ﹤0.01% 1082
2024
Q4 		$5.72K Hold
87
– – ﹤0.01% 1101
2024
Q3 		$5.93K Hold
87
– – ﹤0.01% 1113
2024
Q2 		$5.77K Hold
87
– – ﹤0.01% 1058
2024
Q1 		$5.71K Buy
+87
New +$5.75K ﹤0.01% 1045

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Continuum Advisory's IHE Position: Q2 2025 in Review

Continuum Advisory sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2025, closing a stake of 87 shares — an estimated $6.14K sold.

Continuum Advisory first reported a position in IHE in Q1 2024 and held it in 5 quarters. The position peaked at $6.14K in Q1 2025. 139 funds tracked by Wall St. Rank hold IHE as of Q2 2025.

  • Continuum Advisory reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 87 iShares US Pharmaceuticals ETF shares in Q2 2025, an estimated $6.14K.
  • Continuum Advisory first reported a position in iShares US Pharmaceuticals ETF in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's iShares US Pharmaceuticals ETF position peaked at $6.14K in Q1 2025.
  • 139 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.